Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
71.25 CHF | +1.06% | -1.40% | +38.51% |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 1.25B | |
+39.67% | 734B | |
+32.83% | 591B | |
-6.42% | 350B | |
+15.91% | 315B | |
+1.97% | 276B | |
+14.92% | 238B | |
+9.40% | 206B | |
-5.32% | 204B | |
+5.56% | 161B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Licenses Topical Acne Medication to Hyundai Pharmaceuticals in South Korea